Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Finished Goods (2016 - 2025)

Orthofix Medical's Finished Goods history spans 15 years, with the latest figure at $86.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Finished Goods fell 18.18% year-over-year to $86.2 million, compared with a TTM value of $86.2 million through Dec 2025, down 18.18%, and an annual FY2025 reading of $86.2 million, down 18.18% over the prior year.
  • Finished Goods for Q4 2025 was $86.2 million at Orthofix Medical, down from $88.3 million in the prior quarter.
  • The five-year high for Finished Goods was $140.7 million in Q3 2023, with the low at $14.7 million in Q2 2021.
  • Average Finished Goods over 5 years is $84.1 million, with a median of $87.2 million recorded in 2025.
  • Year-over-year, Finished Goods crashed 48.91% in 2021 and then skyrocketed 471.49% in 2023.
  • Tracing OFIX's Finished Goods over 5 years: stood at $58.3 million in 2021, then increased by 9.58% to $63.9 million in 2022, then surged by 119.6% to $140.3 million in 2023, then fell by 24.89% to $105.4 million in 2024, then fell by 18.18% to $86.2 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Finished Goods are $86.2 million (Q4 2025), $88.3 million (Q3 2025), and $85.0 million (Q2 2025).